Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
Thomas M. Ashton, W. Gillies McKenna, Leoni A. Kunz‐Schughart, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 11, pp. 2482-2490
Open Access | Times Cited: 895

Showing 1-25 of 895 citing articles:

Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets
Jae Hyung Park, Woo Yang Pyun, Hyun Woo Park
Cells (2020) Vol. 9, Iss. 10, pp. 2308-2308
Open Access | Times Cited: 403
Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation
Chelsea Schiliro, Bonnie L. Firestein
Cells (2021) Vol. 10, Iss. 5, pp. 1056-1056
Open Access | Times Cited: 381
Therapeutic targeting of the hypoxic tumour microenvironment
Dean C. Singleton, Andrew Macann, William R. Wilson
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 12, pp. 751-772
Closed Access | Times Cited: 334
Autophagy: Regulator of cell death
ShiZuo Liu, ShuaiJie Yao, Huan Yang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 10
Open Access | Times Cited: 327
Metabolism of pancreatic cancer: paving the way to better anticancer strategies
Qin Cheng, Gang Yang, Jinshou Yang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 297
Altered cellular metabolism in gliomas — an emerging landscape of actionable co-dependency targets
Junfeng Bi, Sudhir Chowdhry, Sihan Wu, et al.
Nature reviews. Cancer (2019) Vol. 20, Iss. 1, pp. 57-70
Closed Access | Times Cited: 286
Lactate in the tumour microenvironment: From immune modulation to therapy
Zi-Hao Wang, Wenbei Peng, Pei Zhang, et al.
EBioMedicine (2021) Vol. 73, pp. 103627-103627
Open Access | Times Cited: 276
Role of NAD+ in regulating cellular and metabolic signaling pathways
Sara Amjad, Sabah Nisar, Ajaz A. Bhat, et al.
Molecular Metabolism (2021) Vol. 49, pp. 101195-101195
Open Access | Times Cited: 217
Targeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy
Sarah‐Maria Fendt, Christian Frezza, Ayelet Erez
Cancer Discovery (2020) Vol. 10, Iss. 12, pp. 1797-1807
Open Access | Times Cited: 215
Self-Delivery Nanomedicine for O2-Economized Photodynamic Tumor Therapy
Linping Zhao, Rongrong Zheng, Hua-Qing Chen, et al.
Nano Letters (2020) Vol. 20, Iss. 3, pp. 2062-2071
Closed Access | Times Cited: 204
Mitochondria Targeting as an Effective Strategy for Cancer Therapy
Poorva Ghosh, Chantal Vidal, Sanchareeka Dey, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3363-3363
Open Access | Times Cited: 199
Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells
Xuemei Yao, Wei Li, De Fang, et al.
Advanced Science (2021) Vol. 8, Iss. 22
Open Access | Times Cited: 189
Mitochondria in cancer
Debora Grasso, Luca X. Zampieri, Tânia Capelôa, et al.
Cell Stress (2020) Vol. 4, Iss. 6, pp. 114-146
Open Access | Times Cited: 182
Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis
Divya Ramchandani, Mirela Berisa, Diamile A. Tavarez, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 182
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
Peijie Zheng, Chuntao Zhou, Liuyi Lu, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 180
Carbon Ion Radiobiology
Walter Tinganelli, Marco Durante
Cancers (2020) Vol. 12, Iss. 10, pp. 3022-3022
Open Access | Times Cited: 175
Metabolic Reprogramming in Triple-Negative Breast Cancer
Xiangyu Sun, Mozhi Wang, Mengshen Wang, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 170
Oxidative phosphorylation as a potential therapeutic target for cancer therapy
Valentina Sica, José Manuel Bravo‐San Pedro, Gautier Stoll, et al.
International Journal of Cancer (2019) Vol. 146, Iss. 1, pp. 10-17
Open Access | Times Cited: 168
Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy
Jenna L. Carter, Katie Hege, Jay Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 166
The Mitochondrion as an Emerging Therapeutic Target in Cancer
Katherine G. Roth, Isa Mambetsariev, Prakash Kulkarni, et al.
Trends in Molecular Medicine (2019) Vol. 26, Iss. 1, pp. 119-134
Open Access | Times Cited: 165
Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer
Lianhui Sun, Yuan Zhang, Boyu Yang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 159
STAT proteins in cancer: orchestration of metabolism
Yijia Li, Chunyan Zhang, Antons Martincuks, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 3, pp. 115-134
Closed Access | Times Cited: 154
Metabolic Codependencies in the Tumor Microenvironment
Prasenjit Dey, Alec C. Kimmelman, Ronald A. DePinho
Cancer Discovery (2021) Vol. 11, Iss. 5, pp. 1067-1081
Open Access | Times Cited: 150
Overcoming Hypoxia by Multistage Nanoparticle Delivery System to Inhibit Mitochondrial Respiration for Photodynamic Therapy
Donglin Xia, Peipei Xu, Xingyu Luo, et al.
Advanced Functional Materials (2019) Vol. 29, Iss. 13
Closed Access | Times Cited: 149
Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter
Tord Hompland, Christina S. Fjeldbo, Heidi Lyng
Cancers (2021) Vol. 13, Iss. 3, pp. 499-499
Open Access | Times Cited: 134
Page 1 - Next Page

Scroll to top